Basic information |
Metabolite name | Glutamate and Glutamine |
N/A | |
N/A | |
N/A | |
Synonyms | Glutamine and Glutamate |
No. of studies | 32 |
Relationship between Glutamate and Glutamine and depression (count: 32) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M1058 | Type1 | depression group vs. control group | Dorsal thalamus | Human | Down |
Study M1080 | Type2 | non-refractory depression group, post 3-week treatment vs. baseline | Hippocampus | Human | Up |
Study M1080 | Type4 | non-refractory depression group vs. refractory depression group, post 3-week treatment | Hippocampus | Human | Up |
Study M188 | Type1 | CFSS group vs. control group | Prefrontal cortex | Wistar rat | Down |
Study M194 | Type1 | CFSS group vs. control group | Prefrontal cortex | Wistar rat | Down |
Study M218 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Down |
Study M229 | Type1 | depression group vs. depression control group | Amygdala | Human | Down |
Study M230 | Type3 | rTMS-treated one session post-treatment vs. pre-treatment | Dorsolateral prefrontal cortex | Human | Down |
Study M230 | Type3 | rTMS-treated five session post-treatment vs. sham-treated | Anterior cingulate cortex | Human | Up |
Study M234 | Type1 | depression group vs. control group | Dorsolateral prefrontal cortex | Human | Down |
Study M234 | Type2 | ECT-treated responder group post-treatment vs. pre-treatment | Dorsolateral prefrontal cortex | Human | Up |
Study M235 | Type1 | depression group vs. control group | Anterior cingulate | Human | Down |
Study M235 | Type2 | ECT-treated responder group post-treatment vs. pre-treatment | Anterior cingulate | Human | Up |
Study M239 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Down |
Study M241 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Down |
Study M254 | Type1 | depression group vs. control group | Dorsomedial/dorsal anterolateral prefrontal | Human | Down |
Study M254 | Type1 | depression group vs. control group | Ventromedial prefrontal | Human | Down |
Study M258 | Type1 | diabetes with depression group vs. diabetes without depression group | Subcortical nuclei | Human | Down |
Study M296 | Type1 | currently depressed group vs. control group | Hippocampus | Human | Down |
Study M305 | Type1 | chronic depression group vs. control group | Hippocampus | Human | Down |
Study M310 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Down |
Study M310 | Type2 | depression group post-treatment vs. pre-treatment | Anterior cingulate cortex | Human | Up |
Study M325 | Type1 | depression group vs. control group | Medial prefrontal cortex | Human | Down |
Study M327 | Type1 | depression group vs. control group | Medial prefrontal cortex | Human | Down |
Study M333 | Type2 | ketamine-treated depression group post-treatment vs. pre-treatment | Medial prefrontal cortex | Human | Up |
Study M336 | Type1 | depression group vs. control group | Dorsolateral prefrontal cortex | Human | Down |
Study M344 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
Study M344 | Type1 | depression group vs. control group | Subgenual anterior cingulate cortex | Human | Down |
Study M344 | Type2 | ECT-treated depression group vs. control group | Hippocampus | Human | Down |
Study M344 | Type2 | ECT-treated depression group vs. control group | Subgenual anterior cingulate cortex | Human | Up |
Study M346 | Type1 | depression group vs. control group | Dorsolateral prefrontal | Human | Down |
Study M349 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
Study M350 | Type1 | depression group vs. control group | Medial prefrontal cortex | Human | Down |
Study M350 | Type1 | depression group vs. control group | Amygdala | Human | Down |
Study M362 | Type1 | SDS group vs. control group | Medial prefrontal cortex | BALB/c mouse | Down |
Study M461 | Type1 | LD group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Up |
Study M622 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Down |
Study M645 | Type2 | ketamine group, after vs. before treatment | Ventro-medial prefrontal cortex | Human | Down |
Study M655 | Type1 | MDD group vs. control group | Dorsolateral prefrontal cortex | Human | Down |
Study M761 | Type1 | maternal deprivation group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
Study M803 | Type4 | remitter group vs. nonremitter group, post-treatmen | Anterior cingulate cortex | Human | Down |
Study M803 | Type4 | remitter group vs. nonremitter group, at baseline | Anterior cingulate cortex | Human | Up |
Study M837 | Type2 | MDD group, post-treatment vs. baseline | Motor cortex | Human | Up |
Study M837 | Type2 | MDD group, post-treatment vs. baseline | Dorsolateral prefrontal cortex | Human | Up |